473 related articles for article (PubMed ID: 31011252)
1. Update on hepatocellular carcinoma: Pathologists' review.
El Jabbour T; Lagana SM; Lee H
World J Gastroenterol; 2019 Apr; 25(14):1653-1665. PubMed ID: 31011252
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic Characteristics of Hepatocellular Carcinoma With Reactive Ductule-like Components, a Subset of Liver Cancer Currently Classified as Combined Hepatocellular-Cholangiocarcinoma With Stem-Cell Features, Typical Subtype.
Shibahara J; Hayashi A; Misumi K; Sakamoto Y; Arita J; Hasegawa K; Kokudo N; Fukayama M
Am J Surg Pathol; 2016 May; 40(5):608-16. PubMed ID: 26735856
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
[TBL] [Abstract][Full Text] [Related]
4. Updates in the diagnosis of combined hepatocellular-cholangiocarcinoma.
Sciarra A; Park YN; Sempoux C
Hum Pathol; 2020 Feb; 96():48-55. PubMed ID: 31931021
[TBL] [Abstract][Full Text] [Related]
5. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications.
Berretta M; Cavaliere C; Alessandrini L; Stanzione B; Facchini G; Balestreri L; Perin T; Canzonieri V
Oncotarget; 2017 Feb; 8(8):14192-14220. PubMed ID: 28077782
[TBL] [Abstract][Full Text] [Related]
6. Histopathology of hepatocellular carcinoma.
Schlageter M; Terracciano LM; D'Angelo S; Sorrentino P
World J Gastroenterol; 2014 Nov; 20(43):15955-64. PubMed ID: 25473149
[TBL] [Abstract][Full Text] [Related]
7. Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.
Wang AQ; Zheng YC; Du J; Zhu CP; Huang HC; Wang SS; Wu LC; Wan XS; Zhang HH; Miao RY; Sang XT; Zhao HT
World J Gastroenterol; 2016 May; 22(18):4459-65. PubMed ID: 27182157
[TBL] [Abstract][Full Text] [Related]
8. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
[TBL] [Abstract][Full Text] [Related]
9. Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma.
Rastogi A
World J Gastroenterol; 2018 Sep; 24(35):4000-4013. PubMed ID: 30254404
[TBL] [Abstract][Full Text] [Related]
10. Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study.
Zhao Q; Yu WL; Lu XY; Dong H; Gu YJ; Sheng X; Cong WM; Wu MC
Chin J Cancer; 2016 Aug; 35(1):82. PubMed ID: 27552844
[TBL] [Abstract][Full Text] [Related]
11. Natural history and treatment trends in hepatocellular carcinoma subtypes: Insights from a national cancer registry.
Jernigan PL; Wima K; Hanseman DJ; Hoehn RS; Ahmad SA; Shah SA; Abbott DE
J Surg Oncol; 2015 Dec; 112(8):872-6. PubMed ID: 26603598
[TBL] [Abstract][Full Text] [Related]
12. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
Calderaro J; Couchy G; Imbeaud S; Amaddeo G; Letouzé E; Blanc JF; Laurent C; Hajji Y; Azoulay D; Bioulac-Sage P; Nault JC; Zucman-Rossi J
J Hepatol; 2017 Oct; 67(4):727-738. PubMed ID: 28532995
[TBL] [Abstract][Full Text] [Related]
13. Dimensions of hepatocellular carcinoma phenotypic diversity.
Désert R; Nieto N; Musso O
World J Gastroenterol; 2018 Oct; 24(40):4536-4547. PubMed ID: 30386103
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma.
Koh KC; Lee H; Choi MS; Lee JH; Paik SW; Yoo BC; Rhee JC; Cho JW; Park CK; Kim HJ
Am J Surg; 2005 Jan; 189(1):120-5. PubMed ID: 15701504
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular Carcinoma: Histologic Subtypes.
Shafizadeh N; Kakar S
Surg Pathol Clin; 2013 Jun; 6(2):367-84. PubMed ID: 26838979
[TBL] [Abstract][Full Text] [Related]
16. Genetic classification of combined hepatocellular-cholangiocarcinoma.
Fujii H; Zhu XG; Matsumoto T; Inagaki M; Tokusashi Y; Miyokawa N; Fukusato T; Uekusa T; Takagaki T; Kadowaki N; Shirai T
Hum Pathol; 2000 Sep; 31(9):1011-7. PubMed ID: 11014564
[TBL] [Abstract][Full Text] [Related]
17. An update on subtypes of hepatocellular carcinoma: From morphology to molecular.
Vyas M; Jain D
Indian J Pathol Microbiol; 2021 Jun; 64(Supplement):S112-S120. PubMed ID: 34135152
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular Carcinoma: Role of Pathology in the Era of Precision Medicine.
Vyas M; Zhang X
Clin Liver Dis; 2020 Nov; 24(4):591-610. PubMed ID: 33012447
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic histopathology of hepatocellular carcinoma: A case-based review.
Agni RM
Semin Diagn Pathol; 2017 Mar; 34(2):126-137. PubMed ID: 28143798
[TBL] [Abstract][Full Text] [Related]
20. Combined hepatocellular-cholangiocarcinoma: Gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis.
Park SH; Lee SS; Yu E; Kang HJ; Park Y; Kim SY; Lee SJ; Shin YM; Lee MG
J Magn Reson Imaging; 2017 Jul; 46(1):267-280. PubMed ID: 27875000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
